Science covers glycobiology, Linnaeus, and the circadian clock in this week's issue.
Phil Green points out the flaws of continuing to assemble 2x sequences.
Open access is defined -- again.
George Church sells the $1,000 genome.
Members of the US House and Senate meet today to finalize the 2008 Department of Health and Human Services appropriations bill.
Keith Robison blogs about "Easter Eggs."
This week in Nature, there's the Autism Consortium, oomycete effector proteins, mouse spermatogenesis, and more.
The genome of an Abyssinian cat is published.
Doctors don't always know what to do when a newborn is thought to have a rare genetic disease.
A blogger's take on British Telecom's thought for the future of biopharma.
Craig Venter returns to the Colbert Report.
Advice to science grad students: it's hard work.
Theoretical chemist Leslie Orgel dies from pancreatic cancer.
Francis S. Collins is awarded the Presidential Medal of Freedom.
A blogger explains peer review to the industry crowd.
A new book explores evil genes.
Steven Salzberg wonders if "conservative" means "anti-knowledge."
PLoS Computational Biology launches a new series of articles.
Jonathan Eisen lists what he likes about Cold Spring Harbor.
VC biotech funding is decreasing.
"Watson's Folly" is a warning, says Seven Stones blogger.
Nobel laureate Arthur Kornberg dies at 89.
The New York Times points out other Nobel laureates who went off the deep end.
The Economist offers an article on systems biology.
Keith Robison blogs about the second GPCR to be successfully crystallized and have its structure published.
A new study finds that a positive lab environment can encourage undergraduates to continue to perform research.
A new analysis suggests non-US citizen STEM PhDs might pass up jobs at US-based startups due to visa concerns.
A UK survey of researchers who identified as LGBT+ and allies uncovered evidence of unwelcoming workplace climates in the physical sciences.
At the Guardian, the University of Edinburgh's Nikolay Ogryzko argues that universities need to better invest in postdocs' careers.